Alluhaim, W.; Alkhulaifi, M.M.; Alzahrani, R.R.; Alrfaei, B.M.; Yassin, A.E.B.; Alghoribi, M.F.; Alsaadi, A.M.; Al-Asmari, A.I.; Al-Fahad, A.J.; Ali, R.;
et al. Effectiveness of a Novel Liposomal Methylglyoxal–Tobramycin Formulation in Reducing Biofilm Formation and Bacterial Adhesion. Antibiotics 2025, 14, 3.
https://doi.org/10.3390/antibiotics14010003
AMA Style
Alluhaim W, Alkhulaifi MM, Alzahrani RR, Alrfaei BM, Yassin AEB, Alghoribi MF, Alsaadi AM, Al-Asmari AI, Al-Fahad AJ, Ali R,
et al. Effectiveness of a Novel Liposomal Methylglyoxal–Tobramycin Formulation in Reducing Biofilm Formation and Bacterial Adhesion. Antibiotics. 2025; 14(1):3.
https://doi.org/10.3390/antibiotics14010003
Chicago/Turabian Style
Alluhaim, Wed, Manal M. Alkhulaifi, Raghad R. Alzahrani, Bahauddeen M. Alrfaei, Alaa Eldeen B. Yassin, Majed F. Alghoribi, Ahlam M. Alsaadi, Ahmed I. Al-Asmari, Ahmed J. Al-Fahad, Rizwan Ali,
and et al. 2025. "Effectiveness of a Novel Liposomal Methylglyoxal–Tobramycin Formulation in Reducing Biofilm Formation and Bacterial Adhesion" Antibiotics 14, no. 1: 3.
https://doi.org/10.3390/antibiotics14010003
APA Style
Alluhaim, W., Alkhulaifi, M. M., Alzahrani, R. R., Alrfaei, B. M., Yassin, A. E. B., Alghoribi, M. F., Alsaadi, A. M., Al-Asmari, A. I., Al-Fahad, A. J., Ali, R., Alhawiti, N. M., & Halwani, M. A.
(2025). Effectiveness of a Novel Liposomal Methylglyoxal–Tobramycin Formulation in Reducing Biofilm Formation and Bacterial Adhesion. Antibiotics, 14(1), 3.
https://doi.org/10.3390/antibiotics14010003
